406 related articles for article (PubMed ID: 27436156)
1. Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review.
Liu LY; King BA; Craiglow BG
J Am Acad Dermatol; 2016 Oct; 75(4):806-812.e3. PubMed ID: 27436156
[TBL] [Abstract][Full Text] [Related]
2. Alopecia areata and health-related quality of life: a systematic review and meta-analysis.
Rencz F; Gulácsi L; Péntek M; Wikonkál N; Baji P; Brodszky V
Br J Dermatol; 2016 Sep; 175(3):561-71. PubMed ID: 26914830
[TBL] [Abstract][Full Text] [Related]
3. Health-Related Quality of Life (HRQoL) in alopecia areata patients-a secondary analysis of the National Alopecia Areata Registry Data.
Shi Q; Duvic M; Osei JS; Hordinsky MK; Norris DA; Price VH; Amos CI; Christiano AM; Mendoza TR
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S49-50. PubMed ID: 24326555
[TBL] [Abstract][Full Text] [Related]
4. HrQoL in hair loss-affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety.
Russo PM; Fino E; Mancini C; Mazzetti M; Starace M; Piraccini BM
J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):608-611. PubMed ID: 30394586
[TBL] [Abstract][Full Text] [Related]
5. Impact of cyclosporin treatment on health-related quality of life of patients with alopecia areata.
Lai VWY; Chen G; Sinclair R
J Dermatolog Treat; 2021 Mar; 32(2):250-257. PubMed ID: 31389731
[TBL] [Abstract][Full Text] [Related]
6. Severity of disease and quality of life in parents of children with alopecia areata, totalis, and universalis: A prospective, cross-sectional study.
Putterman E; Patel DP; Andrade G; Harfmann KL; Hogeling M; Cheng CE; Goh C; Rogers RS; Castelo-Soccio L
J Am Acad Dermatol; 2019 May; 80(5):1389-1394. PubMed ID: 30633941
[TBL] [Abstract][Full Text] [Related]
7. Assessing quality of life in Alopecia areata patients in China.
Qi S; Xu F; Sheng Y; Yang Q
Psychol Health Med; 2015; 20(1):97-102. PubMed ID: 24628099
[TBL] [Abstract][Full Text] [Related]
8. Clinical profile and impact on quality of life: seven years experience with patients of alopecia areata.
Al-Mutairi N; Eldin ON
Indian J Dermatol Venereol Leprol; 2011; 77(4):489-93. PubMed ID: 21727697
[TBL] [Abstract][Full Text] [Related]
9. PUVA treatment of alopecia areata totalis and universalis: a retrospective study.
Whitmont KJ; Cooper AJ
Australas J Dermatol; 2003 May; 44(2):106-9. PubMed ID: 12752182
[TBL] [Abstract][Full Text] [Related]
10. Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients.
Liu LY; Craiglow BG; Dai F; King BA
J Am Acad Dermatol; 2017 Jan; 76(1):22-28. PubMed ID: 27816293
[TBL] [Abstract][Full Text] [Related]
11. Alopecia areata and overt thyroid diseases: A nationwide population-based study.
Han TY; Lee JH; Noh TK; Choi MW; Yun JS; Lee KH; Bae JM
J Dermatol; 2018 Dec; 45(12):1411-1417. PubMed ID: 30222206
[TBL] [Abstract][Full Text] [Related]
12. Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation.
Glickman JW; Dubin C; Renert-Yuval Y; Dahabreh D; Kimmel GW; Auyeung K; Estrada YD; Singer G; Krueger JG; Pavel AB; Guttman-Yassky E
J Am Acad Dermatol; 2021 Feb; 84(2):370-380. PubMed ID: 32376430
[TBL] [Abstract][Full Text] [Related]
13. Psychiatric symptomatology and health-related quality of life in children and adolescents with alopecia areata.
Bilgiç Ö; Bilgiç A; Bahalı K; Bahali AG; Gürkan A; Yılmaz S
J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1463-8. PubMed ID: 24237476
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis.
Lee HH; Gwillim E; Patel KR; Hua T; Rastogi S; Ibler E; Silverberg JI
J Am Acad Dermatol; 2020 Mar; 82(3):675-682. PubMed ID: 31437543
[TBL] [Abstract][Full Text] [Related]
15. A case-control study on family dysfunction in patients with alopecia areata, psoriasis and atopic dermatitis.
Poot F; Antoine E; Gravellier M; Hirtt J; Alfani S; Forchetti G; Linder D; Abeni D; Tabolli S; Sampogna F
Acta Derm Venereol; 2011 Jun; 91(4):415-21. PubMed ID: 21336474
[TBL] [Abstract][Full Text] [Related]
16. Pediatric Alopecia Areata.
Afford R; Leung AKC; Lam JM
Curr Pediatr Rev; 2021; 17(1):45-54. PubMed ID: 32351186
[TBL] [Abstract][Full Text] [Related]
17. Association of Vitiligo and Alopecia Areata With Atopic Dermatitis: A Systematic Review and Meta-analysis.
Mohan GC; Silverberg JI
JAMA Dermatol; 2015 May; 151(5):522-8. PubMed ID: 25471826
[TBL] [Abstract][Full Text] [Related]
18. Cellular retinol-binding protein-1 expression increases with increasing clinical severity of alopecia areata.
Elmaadawy E; Elgarhy LH; Shareef M
J Cosmet Dermatol; 2019 Apr; 18(2):659-664. PubMed ID: 30556317
[TBL] [Abstract][Full Text] [Related]
19. Alopecia areata in Tunisia: epidemio-clinical aspects and comorbid conditions. A prospective study of 204 cases.
Arousse A; Boussofara L; Mokni S; Gammoudi R; Saidi W; Aounallah A; Belajouza C; Ghariani N; Denguezli M; Nouira R
Int J Dermatol; 2019 Jul; 58(7):811-815. PubMed ID: 30677128
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database.
George P; Jagun O; Liu Q; Wentworth C; Napatalung L; Wolk R; Anway S; Zwillich SH
J Dermatol; 2023 Sep; 50(9):1121-1128. PubMed ID: 37291688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
